Terms: = Pancreatic cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6 AND Prognosis
10 results:
1. Dysregulation of the circ_0087502/miR-1179/tgfbr2 pathway supports gemcitabine resistance in pancreatic cancer.
Chen M; Liu X; Lu J; Teng H; Yu C; Liu Y; Zheng Y
Cancer Biol Ther; 2023 Dec; 24(1):2258566. PubMed ID: 37844011
[TBL] [Abstract] [Full Text] [Related]
2. ST6GALNAC4 promotes hepatocellular carcinogenesis by inducing abnormal glycosylation.
Man D; Jiang Y; Zhang D; Wu J; Ding B; Liu H; Xu G; Lu J; Ru J; Tong R; Zheng S; Chen D; Wu J
J Transl Med; 2023 Jun; 21(1):420. PubMed ID: 37381011
[TBL] [Abstract] [Full Text] [Related]
3. USP33 promotes pancreatic cancer malignant phenotype through the regulation of tgfbr2/TGFβ signaling pathway.
Liu X; Xu J; Shen B; Xu J; Jiang J
Cell Death Dis; 2023 Jun; 14(6):362. PubMed ID: 37322017
[TBL] [Abstract] [Full Text] [Related]
4. Concurrent Activation of Kras and Canonical Wnt Signaling Induces Premalignant Lesions That Progress to Extrahepatic Biliary cancer in Mice.
Nagao M; Fukuda A; Omatsu M; Namikawa M; Sono M; Fukunaga Y; Masuda T; Araki O; Yoshikawa T; Ogawa S; Masuo K; Goto N; Hiramatsu Y; Muta Y; Tsuda M; Maruno T; Nakanishi Y; Taketo MM; Ferrer J; Tsuruyama T; Nakanuma Y; Taura K; Uemoto S; Seno H
Cancer Res; 2022 May; 82(9):1803-1817. PubMed ID: 35247892
[TBL] [Abstract] [Full Text] [Related]
5. The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification.
Yang Y; Ding Y; Gong Y; Zhao S; Li M; Li X; Song G; Zhai B; Liu J; Shao Y; Zhu L; Pang J; Ma Y; Ou Q; Wu X; Zhang Z
BMC Cancer; 2022 Feb; 22(1):186. PubMed ID: 35180847
[TBL] [Abstract] [Full Text] [Related]
6. Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism.
Sano M; Takahashi R; Ijichi H; Ishigaki K; Yamada T; Miyabayashi K; Kimura G; Mizuno S; Kato H; Fujiwara H; Nakatsuka T; Tanaka Y; Kim J; Masugi Y; Morishita Y; Tanaka M; Ushiku T; Nakai Y; Tateishi K; Ishii Y; Isayama H; Moses HL; Koike K
Gut; 2021 Sep; 70(9):1713-1723. PubMed ID: 33087490
[TBL] [Abstract] [Full Text] [Related]
7. Pattern of Invasion in Human pancreatic cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome.
Huang W; Navarro-Serer B; Jeong YJ; Chianchiano P; Xia L; Luchini C; Veronese N; Dowiak C; Ng T; Trujillo MA; Huang B; Pflüger MJ; Macgregor-Das AM; Lionheart G; Jones D; Fujikura K; Nguyen-Ngoc KV; Neumann NM; Groot VP; Hasanain A; van Oosten AF; Fischer SE; Gallinger S; Singhi AD; Zureikat AH; Brand RE; Gaida MM; Heinrich S; Burkhart RA; He J; Wolfgang CL; Goggins MG; Thompson ED; Roberts NJ; Ewald AJ; Wood LD
Cancer Res; 2020 Jul; 80(13):2804-2817. PubMed ID: 32376602
[TBL] [Abstract] [Full Text] [Related]
8. Endoglin (CD105) and SMAD4 regulate spheroid formation and the suppression of the invasive ability of human pancreatic cancer cells.
Kokaji E; Shimomura A; Minamisaka T; Nakajima T; Miwa S; Hatta H; Nishida T; Kiya C; Imura J
Int J Oncol; 2018 Mar; 52(3):892-900. PubMed ID: 29393426
[TBL] [Abstract] [Full Text] [Related]
9. Identification of biomarkers for the prognosis of pancreatic ductal adenocarcinoma with miRNA microarray data.
Wang S; Zhao Y; Li D; Zhu L; Shen Z
Int J Biol Markers; 2015 May; 30(2):e226-33. PubMed ID: 25791160
[TBL] [Abstract] [Full Text] [Related]
10. miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and tgfbr2.
Harazono Y; Muramatsu T; Endo H; Uzawa N; Kawano T; Harada K; Inazawa J; Kozaki K
PLoS One; 2013; 8(5):e62757. PubMed ID: 23690952
[TBL] [Abstract] [Full Text] [Related]
